SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-009995
Filing Date
2019-11-05
Accepted
2019-11-05 17:01:48
Documents
76
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cara-20190930x10q.htm 10-Q 2330500
2 EX-10.1 cara-20190930ex101bba46d.htm EX-10.1 447027
3 EX-31.1 cara-20190930ex31113958c.htm EX-31.1 15260
4 EX-31.2 cara-20190930ex3128e3aca.htm EX-31.2 15372
5 EX-32.1 cara-20190930ex321208c09.htm EX-32.1 11487
  Complete submission text file 0001558370-19-009995.txt   9743479

Data Files

Seq Description Document Type Size
6 EX-101.INS cara-20190930.xml EX-101.INS 2139172
7 EX-101.SCH cara-20190930.xsd EX-101.SCH 56112
8 EX-101.CAL cara-20190930_cal.xml EX-101.CAL 64327
9 EX-101.DEF cara-20190930_def.xml EX-101.DEF 258753
10 EX-101.LAB cara-20190930_lab.xml EX-101.LAB 532301
11 EX-101.PRE cara-20190930_pre.xml EX-101.PRE 444351
Mailing Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902
Business Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902 203-406-3700
Cara Therapeutics, Inc. (Filer) CIK: 0001346830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36279 | Film No.: 191194135
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences